Geneticist Mary-Claire King recently accepted the prestigious Laskar science award and during her acceptance speech, she surprised many by sharing her recommendation that genetic screening for brca1 and brca2 mutations should be made available to all women around age thirty as part of routine medical care. This would be an option, not mandatory.
Ever since I heard about Dr. King’s announcement, I’ve been trying to figure out where I stand on this issue. I have been reading with great interest many of the articles written after her stunning (to some) recommendation. At first I was torn, but after thinking more about it, I know where I stand. (more…)